SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 15th, 2014 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of January 15, 2014, between Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
STRICTLY CONFIDENTIALEngagement Agreement • January 15th, 2014 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations
This letter will confirm our understanding that Rexahn Pharmaceuticals, Inc. (the “Company”) has engaged ROTH Capital Partners, LLC (“ROTH”) to act as the Company’s lead placement agent or lead book running manager in connection with the matters described below, subject to the terms and conditions of this letter agreement (this “Agreement”) and the Offering Agreement referred to below.
